Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (161-170 of 635) with videos related to

Pageof 64
Sort By:
JAMIA Open|February 8, 2023
Design and development of a digital shared decision-making tool for stroke prevention in atrial fibrillationJulio C Nunes, Tina Baykaner, Krishna Pundi, et al.
American Heart Journal|May 16, 2016
Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryAnna Gundlund, Emil Loldrup Fosbøl, Sunghee Kim, et al.
Critical Care Medicine|June 14, 2013
The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarctionSean van Diepen, John P Vavalle, L Kristin Newby, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 18, 2015
Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled TrialGreg Fulcher, David R Matthews, Vlado Perkovic, et al.
Journal of the American College of Cardiology|April 25, 2009
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionPaul W Armstrong, Yuling Fu, Cynthia M Westerhout, et al.
JACC. Heart Failure|December 31, 2016
Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial FibrillationAmbarish Pandey, Sunghee Kim, Curtiss Moore, et al.
Diabetologia|March 15, 2019
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS ProgramDavid R Matthews, Qiang Li, Vlado Perkovic, et al.
Heart (British Cardiac Society)|June 25, 2014
Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromesChristoph Varenhorst, Ulrica Alström, Oscar Ö Braun, et al.
The New England Journal of Medicine|May 24, 2024
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 DiabetesVlado Perkovic, Katherine R Tuttle, Peter Rossing, et al.
Diabetes, Obesity & Metabolism|May 29, 2024
Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trialNavdeep Tangri, Thomas W Ferguson, Ryan J Bamforth, et al.
Pageof 64

Showing results (161-170 of 635) with videos related to

Sort By:
Pageof 64
JAMIA Open|February 8, 2023
Design and development of a digital shared decision-making tool for stroke prevention in atrial fibrillationJulio C Nunes, Tina Baykaner, Krishna Pundi, et al.
American Heart Journal|May 16, 2016
Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryAnna Gundlund, Emil Loldrup Fosbøl, Sunghee Kim, et al.
Critical Care Medicine|June 14, 2013
The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarctionSean van Diepen, John P Vavalle, L Kristin Newby, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 18, 2015
Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled TrialGreg Fulcher, David R Matthews, Vlado Perkovic, et al.
Journal of the American College of Cardiology|April 25, 2009
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionPaul W Armstrong, Yuling Fu, Cynthia M Westerhout, et al.
JACC. Heart Failure|December 31, 2016
Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial FibrillationAmbarish Pandey, Sunghee Kim, Curtiss Moore, et al.
Diabetologia|March 15, 2019
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS ProgramDavid R Matthews, Qiang Li, Vlado Perkovic, et al.
Heart (British Cardiac Society)|June 25, 2014
Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromesChristoph Varenhorst, Ulrica Alström, Oscar Ö Braun, et al.
The New England Journal of Medicine|May 24, 2024
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 DiabetesVlado Perkovic, Katherine R Tuttle, Peter Rossing, et al.
Diabetes, Obesity & Metabolism|May 29, 2024
Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trialNavdeep Tangri, Thomas W Ferguson, Ryan J Bamforth, et al.
Pageof 64